11th International Congress on The Future of Breast Cancer

Venue: Hotel del Coronado

Location: Coronado, California, United States

Event Date/Time: Jul 26, 2012 End Date/Time: Jul 28, 2012
Registration Date: Jul 26, 2012
Report as Spam


The 11th International Congress on The Future of Breast Cancer is an educational and scientific meeting that focuses on the clinical implications of breast cancer genetic and phenotypic subtyping, as well as novel agents and strategies changing the future of breast cancer therapy. New data and promising studies that provide information about how to optimally individualize breast cancer therapy will be discussed, and controversial issues will be debated. The conference provides a unique opportunity for medical, surgical and radiation oncologists and other healthcare professionals to learn from and interact with international leaders in breast cancer in order to increase knowledge, apply new data to practice, and ultimately improve patient outcomes.

Target Audience
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.

Learning Objectives
•Incorporate current guidelines and recent data on local therapy, including new strategies for surgical and radiation therapy, into the treatment of patients with breast cancer
•Integrate biomarkers, molecular assays, and other risk assessment tools in treatment decision-making for breast cancer when appropriate
•Incorporate systemic therapies for breast cancer (including endocrine, cytotoxic, targeted, and bone-modifying agents) into individualized treatment plans for patients based upon an evaluation of efficacy and safety, as well as patient and tumor characteristics
•Evaluate emerging clinical data regarding new agents and evolving strategies for the treatment of breast cancer, and apply clinical trial data appropriately in order to optimize the outcome of individual patients
•Select eligible patients with breast cancer for promising clinical trials


1500 Orange Ave
United States